SIRNAOMICS-B News

SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

May 10 20:51

SIRNAOMICS-B: APPOINTMENT OF EXECUTIVE DIRECTOR

May 10 20:45

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 16:33

SIRNAOMICS-B: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023

Apr 29 12:08

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS RECEIVED FDA SPECIFIC GUIDANCE FOR FURTHER DEVELOPMENT OF STP705 FOR TREATMENT OF SQUAMOUS CELL CARCINOMA IN SITU

Apr 16 22:28

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 16:31

SIRNAOMICS-B: INSIDE INFORMATION

Mar 18 06:05

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 16:31

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - UNUSUAL SHARE PRICE MOVEMENT

Feb 29 20:16

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 5 16:36

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 17:58

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - RNAIMMUNE RECEIVES INVESTIGATIONAL NEW DRUG APPLICATION CLEARANCE FROM U.S. FDA FOR mRNA-BASED RESPIRATORY SYNCYTIAL VIRUS VACCINE RV-1770

Dec 18, 2023 19:54

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES SUCCESSFUL COMPLETION OF COHORT 1 FROM PHASE I CLINICAL STUDY OF GALNAC-BASED RNAi THERAPEUTIC STP122G FOR ANTICOAGULANT TREATMENT

Dec 5, 2023 22:21

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 16:53

SIRNAOMICS-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Nov 30, 2023 22:53

SIRNAOMICS-B: RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGES TO SENIOR MANAGEMENT

Nov 30, 2023 22:47

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 3, 2023 16:50

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS PRESENTS POSITIVE CLINICAL DATA OF STP705 FOR FOCAL FAT REDUCTION

Nov 1, 2023 18:46

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 5, 2023 16:34

SIRNAOMICS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

Sep 5, 2023 17:13